| Institutions |
Authors |
Share |
|
Bristol-Myers Squibb, United States of America (USA)
|
9.000000
|
0.35 |
|
IRCCS National Cancer Institute (INT) Milan, Italy
|
2.000000
|
0.08 |
|
Beijing Cancer Hospital / School of Oncology, PKUHSC, China
|
1.000000
|
0.04 |
|
H. Lee Moffitt Cancer Center & Research Institute, United States of America (USA)
|
1.000000
|
0.04 |
|
Northwestern University (NU), United States of America (USA)
|
1.000000
|
0.04 |
|
Vall d'Hebron University Hospital (HUVH), ICS, Spain
|
1.000000
|
0.04 |
|
National Cancer Institute (INCA), Brazil
|
1.000000
|
0.04 |
|
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)
|
1.000000
|
0.04 |
|
National and Kapodistrian University of Athens (UOA), Greece
|
1.000000
|
0.04 |
|
University of Zurich (UZH), Switzerland
|
1.000000
|
0.04 |
|
Paracelsus Medical University (PMU), Austria
|
1.000000
|
0.04 |
|
Immunology and New Concepts in Immunotherapy (INCIT), France
|
1.000000
|
0.04 |
|
EDOEAP, Greece
|
1.000000
|
0.04 |
|
Bristol-Myers Squibb Pharmaceuticals Limited UK, United Kingdom (UK)
|
1.000000
|
0.04 |
|
The University of Texas MD Anderson Cancer Center, United States of America (USA)
|
1.000000
|
0.04 |
|
Melanoma Institute Australia, Australia
|
0.500000
|
0.02 |
|
St Vincent's Health Australia, Australia
|
0.500000
|
0.02 |
|
National Center for Tumor Diseases West (NCT West), Germany
|
0.500000
|
0.02 |
|
DKTK Partner Site Essen/Düsseldorf, Germany
|
0.500000
|
0.02 |
